Protalix BioTherapeutics
PLX
#8576
Rank
A$0.18 B
Marketcap
$2.55
Share price
-1.78%
Change (1 day)
18.48%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): -A$19.77 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$38.05 Million. In 2023 the company made an earning of A$18.03 Million, an increase over its 2022 earnings that were of -A$18.21 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$19.77 Million-209.6%
2023 A$18.03 M-199.05%
2022 -A$18.21 Million-40.38%
2021 -A$30.55 Million-732.31%
2020 A$4.82 M-130.53%
2019 -A$15.82 Million189.85%
2018 -A$5.46 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$28.41 Million-32.37%
2015 -A$42 Million10.11%
2014 -A$38.14 Million-7.59%
2013 -A$41.28 Million
2011 -A$47.8 Million-19.39%
2010 -A$59.29 Million20.87%
2009 -A$49.05 Million32.26%
2008 -A$37.09 Million-5.46%
2007 -A$39.23 Million
2004 -A$0.26 Million12.35%
2003 -A$0.23 Million-11.1%
2002 -A$0.26 Million-57.03%
2001 -A$0.6 Million1.03%
2000 -A$0.59 Million-53.22%
1999 -A$1.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.16 Billion 658.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.00 B-5,090.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$1.86 Billion 9,110.43%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.26 B-6,384.67%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel